BMS-5, 98%, a potent LIMK inhibitor

Name: BMS-5, 98%, a potent LIMK inhibitor | 1338247-35-0
Brand: J&K Chemical
SKU: JK1867994_5_MG
Price: 114.0 USD
Availability: OutOfStock

Cat. No JK1867994_5_MG

Vendor: J&K Chemical

Product Information

Product Name

BMS-5, 98%, a potent LIMK inhibitor

Brand Name

J&K

Product Number

1867994

CAS

1338247-35-0

SDS Document

View/Download

Certificate of Analysis (COA)

COA not found

General Information

PubChem CID

56965901

IUPAC Name

N-5-1-(2,6-dichlorophenyl)-3-(difluoromethyl)pyrazol-5-yl-1,3-thiazol-2-yl-2-methylpropanamide

InChI Key

IVUGBSGLHRJSSP-UHFFFAOYSA-N

SMILES

CC(C)C(=O)NC1=NC=C(S1)C2=CC(=NN2C3=C(C=CC=C3Cl)Cl)C(F)F

Safety Information

Storage Condition

Freezer -20℃

References Data Source From Pubchem

Tetrahydropyridine LIMK inhibitors: Structure activity studies and biological characterization

Publication Name: European Journal of Medicinal Chemistry

Publication Date: 2024-05-05

DOI: 10.1016/j.ejmech.2024.116391

Inhibition of airway smooth muscle contraction and proliferation by LIM kinase inhibitor, LIMKi3

Publication Name: Advances in Medical Sciences

Publication Date: 2023-09

DOI: 10.1016/j.advms.2023.04.002

Drug combinations identified by high-throughput screening promote cell cycle transition and upregulate Smad pathways in myeloma

Publication Name: Cancer Letters

Publication Date: 2023-08-01

DOI: 10.1016/j.canlet.2023.216284

BLM overexpression as a predictive biomarker for CHK1 inhibitor response in PARP inhibitor–resistant BRCA -mutant ovarian cancer

Publication Name: Science Translational Medicine

Publication Date: 2023-06-21

DOI: 10.1126/scitranslmed.add7872

High-throughput and targeted drug screens identify pharmacological candidates against MiT-translocation renal cell carcinoma

Publication Name: Journal of experimental & clinical cancer research : CR

Publication Date: 2023-04-25

DOI: 10.1186/s13046-023-02667-4

BMS-5, 98%, a potent LIMK inhibitor

Product Information

General Information

Safety Information

References Data Source From Pubchem

Tetrahydropyridine LIMK inhibitors: Structure activity studies and biological characterization

Inhibition of airway smooth muscle contraction and proliferation by LIM kinase inhibitor, LIMKi3

Drug combinations identified by high-throughput screening promote cell cycle transition and upregulate Smad pathways in myeloma

BLM overexpression as a predictive biomarker for CHK1 inhibitor response in PARP inhibitor–resistant BRCA -mutant ovarian cancer

High-throughput and targeted drug screens identify pharmacological candidates against MiT-translocation renal cell carcinoma